Fierce Healthcare December 7, 2022
Teresa Carey

The healthcare industry is grappling with rising drug prices. The expectation is, though, that the wave of biosimilars launching next year will make a dent in healthcare costs. Paige Minemyer interviews Alan Lotvin, M.D., president of CVS Health’s Caremark pharmacy benefit manager, about biosimilars’ potential.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
How our genome is like a generative AI model
Can Pfizer, Sangamo energise haemophilia A gene therapy?
Pharma Pulse 7/25/24: Driving CAR-Ts for Treatment in Cancer and Immunology, CrowdStrike Explains What Went Wrong in Global Outage & more
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
PacBio, FormBio Unifying AAV Industry, Insilico Medicine Introduces New Products, More

Share This Article